OR2F1 Activators
OR2F1 activators are a category of chemical compounds that interact specifically with the OR2F1 receptor, which is a type of olfactory receptor. Olfactory receptors (ORs) are a large family of G protein-coupled receptors (GPCRs) that detect volatile compounds and play a key role in the sense of smell. Each receptor in this family is tuned to recognize particular molecular features, triggering a signal transduction pathway that initiates a sensory response. OR2F1, like other olfactory receptors, is embedded in the membrane of olfactory sensory neurons and is responsible for the detection of odorant molecules. Activators of OR2F1 bind to this receptor and induce a conformational change that leads to the activation of the receptor, enabling it to initiate a cellular response to the presence of specific odorant molecules.
Chemically, OR2F1 activators are diverse, reflecting the broad range of structural motifs capable of binding to the receptor. They typically possess molecular features that are complementary to the binding site of the OR2F1 receptor, allowing for interactions such as hydrogen bonding, hydrophobic forces, and Van der Waals forces. The specificity of an OR2F1 activator is determined by its ability to fit within the unique three-dimensional structure of the receptor's binding pocket. This interaction is highly selective, with each activator eliciting a response from only a subset of olfactory receptors. The structure-activity relationship (SAR) of these compounds is complex, as minor modifications to their chemical structure can significantly alter their ability to activate the receptor. As such, the development of OR2F1 activators involves intricate chemical synthesis and detailed analysis of the receptor-ligand interactions to ensure specificity and efficacy in binding.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylate cyclase, leading to an increase in cAMP levels. Elevated cAMP activates PKA, which could phosphorylate proteins involved in the olfactory signaling cascade, ultimately potentiating the signal detection function of OR2F1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. The increased levels of cAMP may then activate PKA, enhancing phosphorylation of proteins in the olfactory transduction pathway, thereby indirectly enhancing the activity of OR2F1. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibits phosphodiesterase 5 (PDE5), leading to increased cGMP levels which can enhance the activity of cGMP-dependent protein kinases (PKG). PKG activation might contribute to the phosphorylation of components in the olfactory transduction pathway, potentially enhancing the functional activity of OR2F1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased cAMP levels which in turn activates PKA. PKA may phosphorylate targets within the olfactory signaling pathway, thereby enhancing the sensitivity and function of OR2F1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that is resistant to degradation by phosphodiesterases, thereby effectively increasing cAMP levels within the cell. This can lead to the activation of PKA, and subsequent phosphorylation of proteins within the olfactory signaling pathway, potentially leading to enhanced activation of OR2F1. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
By inhibiting PDE3, it leads to increased cAMP levels within the cell, which can activate PKA. PKA potentially phosphorylates targets in the olfactory transduction pathway, thus enhancing the functional activity of OR2F1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that activates PKA by mimicking the action of cAMP. The activation of PKA may lead to phosphorylation of proteins within the olfactory transduction pathway, which could enhance the function of OR2F1. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Acts as a PDE1 inhibitor, leading to increased levels of cAMP and cGMP. This could activate PKA and PKG, potentially enhancing phosphorylation of components within the olfactory transduction pathway, thereby indirectly enhancing the activity of OR2F1. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Inhibits PDE3, leading to increased cAMP levels within the cell, which activates PKA. Activation of PKA could lead to enhanced phosphorylation of proteins involved in the olfactory transduction pathway, potentially leading to increased functional activity of OR2F1. | ||||||